BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 34255338)

  • 1. The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology.
    Tufano A; Coppola A; Galderisi M
    Semin Thromb Hemost; 2021 Nov; 47(8):899-906. PubMed ID: 34255338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardio-oncology - strategies for management of cancer-therapy related cardiovascular disease.
    Totzeck M; Schuler M; Stuschke M; Heusch G; Rassaf T
    Int J Cardiol; 2019 Apr; 280():163-175. PubMed ID: 30661849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Cardiovascular Complications of Cancer Therapy: Epidemiology, Risk Prediction, and Prevention.
    Narayan V; Ky B
    Annu Rev Med; 2018 Jan; 69():97-111. PubMed ID: 29414258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies - part 1.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):875-892. PubMed ID: 30126304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system.
    Babiker HM; McBride A; Newton M; Boehmer LM; Drucker AG; Gowan M; Cassagnol M; Camenisch TD; Anwer F; Hollands JM
    Crit Rev Oncol Hematol; 2018 Jun; 126():186-200. PubMed ID: 29759560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiotoxicity of anticancer therapies. Towards the implementation of cardio-oncology units].
    Hameau R; Gabrielli L; Garrido M; Guzmán AM; Retamal I; Vacarezza MJ; Greig D; Ocqueteau M; Sánchez C; Pizarro M; Corvalán A; Lavandero S; Castro PF; Martínez G
    Rev Med Chil; 2018 Jan; 146(1):68-77. PubMed ID: 29806680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies.
    Bychowski J; Sobiczewski W
    Cancer Med; 2023 Jul; 12(13):14545-14555. PubMed ID: 37102247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension management in cardio-oncology.
    Essa H; Dobson R; Wright D; Lip GYH
    J Hum Hypertens; 2020 Oct; 34(10):673-681. PubMed ID: 32747676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
    Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM
    J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment.
    Chow EJ; Leger KJ; Bhatt NS; Mulrooney DA; Ross CJ; Aggarwal S; Bansal N; Ehrhardt MJ; Armenian SH; Scott JM; Hong B
    Cardiovasc Res; 2019 Apr; 115(5):922-934. PubMed ID: 30768157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2.
    Manolis AA; Manolis TA; Mikhailidis DP; Manolis AS
    Expert Opin Drug Saf; 2018 Sep; 17(9):893-915. PubMed ID: 30126303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiooncology-dealing with modern drug treatment, long-term complications, and cancer survivorship.
    de Wall C; Bauersachs J; Berliner D
    Clin Exp Metastasis; 2021 Aug; 38(4):361-371. PubMed ID: 34117981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Onco-Cardiology - From the Standpoint of Cardiology].
    Shioyama W
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2052-2057. PubMed ID: 29361616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment recommendations in cardio-oncology: where are we?].
    Müller OJ; Baldus CD
    Internist (Berl); 2020 Nov; 61(11):1125-1131. PubMed ID: 33025122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive review on cardio-oncology: Role of multimodality imaging.
    Chen-Scarabelli C; McRee C; Leesar MA; Hage FG; Scarabelli TM
    J Nucl Cardiol; 2017 Jun; 24(3):906-935. PubMed ID: 27225513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardio-Oncology for the Primary Care Provider.
    Jhawar N; Mcpherson A; Chirila R; Ray J
    Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardio-oncology: conflicting priorities of anticancer treatment and cardiovascular outcome.
    Tilemann LM; Heckmann MB; Katus HA; Lehmann LH; Müller OJ
    Clin Res Cardiol; 2018 Apr; 107(4):271-280. PubMed ID: 29453595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardio-oncology: A Focus on Cardiotoxicity.
    Koutsoukis A; Ntalianis A; Repasos E; Kastritis E; Dimopoulos MA; Paraskevaidis I
    Eur Cardiol; 2018 Aug; 13(1):64-69. PubMed ID: 30310475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.